recombinant adenovirus vector vaccine targeting MUC1 (MicroVax)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Namerecombinant adenovirus vector vaccine targeting MUC1 (MicroVax)
Drug Alias Namead-sig-hMUC-1/ecdCD40L vaccine (MicroVAX)dual CD40 costimulator/MUC1 antigen (MicroVAX)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionMucin-1 modulatorsDendritic cells stimulantsMacrophages stimulants +[5] 
TargetsMucin-1Tumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySingapore
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMicrovax Llc
China Registration ClassN/A

Develop Information

Active CompaniesMicrovax Llc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A